These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients. D'Angelillo RM, Sciuto R, Ramella S, Papalia R, Jereczek-Fossa BA, Trodella LE, Fiore M, Gallucci M, Maini CL, Trodella L. Int J Radiat Oncol Biol Phys; 2014 Oct 01; 90(2):296-302. PubMed ID: 25084612 [Abstract] [Full Text] [Related]
24. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy. Morigi JJ, Stricker PD, van Leeuwen PJ, Tang R, Ho B, Nguyen Q, Hruby G, Fogarty G, Jagavkar R, Kneebone A, Hickey A, Fanti S, Tarlinton L, Emmett L. J Nucl Med; 2015 Aug 01; 56(8):1185-90. PubMed ID: 26112024 [Abstract] [Full Text] [Related]
25. [11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging. Giovacchini G, Picchio M, Briganti A, Cozzarini C, Scattoni V, Salonia A, Landoni C, Gianolli L, Di Muzio N, Rigatti P, Montorsi F, Messa C. J Urol; 2010 Sep 01; 184(3):938-43. PubMed ID: 20643445 [Abstract] [Full Text] [Related]
26. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer. Zattoni F, Agostini E, Cattaneo F, Maruzzo M, Basso U, Zattoni F, Evangelista L. Clin Imaging; 2017 Sep 01; 43():110-116. PubMed ID: 28278446 [Abstract] [Full Text] [Related]
27. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer. Fodor A, Berardi G, Fiorino C, Picchio M, Busnardo E, Kirienko M, Incerti E, Dell'Oca I, Cozzarini C, Mangili P, Pasetti M, Calandrino R, Gianolli L, Di Muzio NG. BJU Int; 2017 Mar 01; 119(3):406-413. PubMed ID: 27104782 [Abstract] [Full Text] [Related]
30. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer. von Eyben FE, Kairemo K. Nucl Med Commun; 2014 Mar 01; 35(3):221-30. PubMed ID: 24240194 [Abstract] [Full Text] [Related]
31. (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series. Graziani T, Ceci F, Castellucci P, Polverari G, Lima GM, Lodi F, Morganti AG, Ardizzoni A, Schiavina R, Fanti S. Eur J Nucl Med Mol Imaging; 2016 Oct 01; 43(11):1971-9. PubMed ID: 27277279 [Abstract] [Full Text] [Related]
32. Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with 11C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging. Sobol I, Zaid HB, Haloi R, Mynderse LA, Froemming AT, Lowe VJ, Davis BJ, Kwon ED, Karnes RJ. J Urol; 2017 Jan 01; 197(1):129-134. PubMed ID: 27449262 [Abstract] [Full Text] [Related]
34. First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches. Schiavina R, Concetti S, Brunocilla E, Nanni C, Borghesi M, Gentile G, Cevenini M, Bianchi L, Molinaroli E, Fanti S, Martorana G. Urol Int; 2014 Jan 01; 92(2):242-5. PubMed ID: 24334968 [Abstract] [Full Text] [Related]
35. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Reske SN, Blumstein NM, Glatting G. Eur J Nucl Med Mol Imaging; 2008 Jan 01; 35(1):9-17. PubMed ID: 17828534 [Abstract] [Full Text] [Related]
36. The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link? Giovacchini G, Ciarmiello A, Giovannini E, Fodor A, Cozzarini C, Mapelli P, Incerti E, Di Muzio N, Gianolli L, Picchio M. Eur J Nucl Med Mol Imaging; 2018 Jun 01; 45(6):962-969. PubMed ID: 29453702 [Abstract] [Full Text] [Related]
37. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer]. García JR, Soler M, Blanch MA, Ramírez I, Riera E, Lozano P, Pérez X, Delgado E, Carrio I, Lomeña F. Rev Esp Med Nucl; 2009 Jun 01; 28(3):95-100. PubMed ID: 19558948 [Abstract] [Full Text] [Related]
38. (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. Kjölhede H, Ahlgren G, Almquist H, Liedberg F, Lyttkens K, Ohlsson T, Bratt O. World J Urol; 2015 Nov 01; 33(11):1749-52. PubMed ID: 25824540 [Abstract] [Full Text] [Related]
39. Imaging prostate cancer with 11C-choline PET/CT. Reske SN, Blumstein NM, Neumaier B, Gottfried HW, Finsterbusch F, Kocot D, Möller P, Glatting G, Perner S. J Nucl Med; 2006 Aug 01; 47(8):1249-54. PubMed ID: 16883001 [Abstract] [Full Text] [Related]
40. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma. Reske SN, Moritz S, Kull T. Q J Nucl Med Mol Imaging; 2012 Oct 01; 56(5):430-9. PubMed ID: 23069922 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]